» Authors » Ehsan Rahimy

Ehsan Rahimy

Explore the profile of Ehsan Rahimy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 134
Citations 1751
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Alshaikhsalama A, Alsoudi A, Wai K, Koo E, Mruthyunjaya P, Rahimy E
Ophthalmol Retina . 2025 Feb; PMID: 39923897
No abstract available.
2.
Zhao C, Chwialkowski K, Wai K, Mruthyunjaya P, Rahimy E, Koo E
Am J Ophthalmol . 2025 Jan; 272:106-116. PMID: 39826858
Objective: To compare cataract surgery complications in patients with and without prior intravitreal injection (IVI). Design: A retrospective cohort study using the TriNetX aggregated research network. Subjects: Patients with IVI...
3.
Nangia P, Wai K, Scott A, Rahimy E, Mruthyunjaya P
Am J Hematol . 2025 Jan; 100(3):490-492. PMID: 39754742
No abstract available.
4.
Alshaikhsalama A, Alsoudi A, Wai K, Koo E, Mruthyunjaya P, Rahimy E
Ophthalmol Retina . 2024 Dec; PMID: 39662591
Objective: To evaluate the risk of age-related macular degeneration (AMD) development and progression in individuals with diagnosed obstructive sleep apnea (OSA). Design: Retrospective cohort study. Subjects: Before propensity score matching...
5.
Borkar D, Rahimy E, Khan M, Ho A, Hatfield M, Nguyen T, et al.
Ophthalmol Retina . 2024 Nov; 9(3):299-301. PMID: 39571793
No abstract available.
6.
Quiruz L, Yavari N, Kikani B, Gupta A, Wai K, Kossler A, et al.
Am J Ophthalmol . 2024 Nov; 270():278-279. PMID: 39528009
No abstract available.
7.
Shah S, Sokol J, Wai K, Rahimy E, Myung D, Mruthyunjaya P, et al.
JAMA Ophthalmol . 2024 Oct; 142(12):1171-1173. PMID: 39480408
No abstract available.
8.
Alsoudi A, Wai K, Koo E, Mruthyunjaya P, Rahimy E
JAMA Ophthalmol . 2024 Oct; 142(12):1114-1121. PMID: 39446346
Importance: Curcuma-based nutritional supplements (CBNS) are natural anti-inflammatory and antioxidant agents that may confer benefits against age-related macular degeneration (AMD). Objective: To examine the association between the use of CBNS...
9.
Alsoudi A, Wai K, Koo E, McConnell R, Pham N, Do B, et al.
Ocul Immunol Inflamm . 2024 Oct; 32(10):2486-2493. PMID: 39401331
Purpose: Patients with Crohn's disease (CD) and subsequent ocular manifestations may have worse outcomes when compared to matched patients with CD without ocular disease. Methods: In this retrospective cohort study,...
10.
Quiruz L, Yavari N, Kikani B, Gupta A, Wai K, Kossler A, et al.
Am J Ophthalmol . 2024 Sep; 268:348-359. PMID: 39271090
Purpose: Assessing immune-related ocular toxicities from immune checkpoint inhibitors (ICIs) is crucial, though rare. This study, utilizing real-world data, examines the occurrence of ophthalmic immune-related adverse events (irAEs) after ICI...